Free Trial

Fulcrum Therapeutics (FULC) SEC Filings & 10K Form

Fulcrum Therapeutics logo
$3.26
+0.05 (+1.56%)
(As of 11/4/2024 ET)

Recent Fulcrum Therapeutics SEC Filings

DateFilerForm TypeView
11/04/2024
10:49 AM
Fulcrum Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/07/2024
10:37 AM
FMR LLC (Filed by)
Fulcrum Therapeutics (Subject)
Form SC 13G/A
09/24/2024
3:05 PM
Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM
Fulcrum Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
3:21 PM
Fulcrum Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
09/16/2024
7:21 PM
Fulcrum Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
09/12/2024
11:43 AM
Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:16 PM
Fulcrum Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
08/22/2024
3:02 PM
Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
6:55 AM
Fulcrum Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/31/2024
6:10 AM
Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
6:15 AM
Fulcrum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
7:00 AM
Fulcrum Therapeutics (Issuer)
Sapir Alex (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:37 PM
Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:15 AM
Fulcrum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
6:05 AM
Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:10 PM
Fulcrum Therapeutics (Issuer)
Tourangeau Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
11:15 PM
Fulcrum Therapeutics (Filer)
Form EFFECT
03/20/2024
3:10 PM
Fulcrum Therapeutics (Issuer)
Horn Patrick Taylor (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2024
3:15 PM
Fulcrum Therapeutics (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:00 PM
Fulcrum Therapeutics (Subject)
Tourangeau Greg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
5:05 PM
Fulcrum Therapeutics (Issuer)
Tourangeau Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:01 AM
Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:53 AM
Fulcrum Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2024
11:08 AM
Fulcrum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/07/2024
6:44 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Fulcrum Therapeutics (Subject)
Form SC 13G/A
01/30/2024
8:00 PM
Fulcrum Therapeutics (Issuer)
Oltmans Curtis Gale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
8:05 PM
Fulcrum Therapeutics (Issuer)
Musso Alan A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
8:10 PM
Fulcrum Therapeutics (Issuer)
Tourangeau Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
6:02 AM
Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
6:05 AM
Fulcrum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FULC) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners